Medical Care
Global Alzheimer’s Disease Diagnostic Market Research Report 2025
- Sep 18, 25
- ID: 507451
- Pages: 82
- Figures: 89
- Views: 21
This report aims to provide a comprehensive presentation of the global market for Alzheimer’s Disease Diagnostic, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Alzheimer’s Disease Diagnostic.
The Alzheimer’s Disease Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer’s Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer’s Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Novartis
Merck
F. Hoffmann-La Roche
Pfizer
TauRx
Alector
Accera
Treventis Corporation
Neuro-Bio
Cognition Therapeutics
Segment by Type
Nervous System Examination
Genetic Testing
Minor Mental State Examination (Mmse)
Brain Imaging
Segment by Application
Early-Onset Alzheimer's Disease
Familial Alzheimer's Disease
Late-Onset Alzheimer's Disease
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer’s Disease Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The Alzheimer’s Disease Diagnostic market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Alzheimer’s Disease Diagnostic market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Alzheimer’s Disease Diagnostic companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Eli Lilly and Company
Novartis
Merck
F. Hoffmann-La Roche
Pfizer
TauRx
Alector
Accera
Treventis Corporation
Neuro-Bio
Cognition Therapeutics
Segment by Type
Nervous System Examination
Genetic Testing
Minor Mental State Examination (Mmse)
Brain Imaging
Segment by Application
Early-Onset Alzheimer's Disease
Familial Alzheimer's Disease
Late-Onset Alzheimer's Disease
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Alzheimer’s Disease Diagnostic company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer’s Disease Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nervous System Examination
1.2.3 Genetic Testing
1.2.4 Minor Mental State Examination (Mmse)
1.2.5 Brain Imaging
1.3 Market by Application
1.3.1 Global Alzheimer’s Disease Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Early-Onset Alzheimer's Disease
1.3.3 Familial Alzheimer's Disease
1.3.4 Late-Onset Alzheimer's Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer’s Disease Diagnostic Market Perspective (2020-2031)
2.2 Global Alzheimer’s Disease Diagnostic Growth Trends by Region
2.2.1 Global Alzheimer’s Disease Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alzheimer’s Disease Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Alzheimer’s Disease Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Alzheimer’s Disease Diagnostic Market Dynamics
2.3.1 Alzheimer’s Disease Diagnostic Industry Trends
2.3.2 Alzheimer’s Disease Diagnostic Market Drivers
2.3.3 Alzheimer’s Disease Diagnostic Market Challenges
2.3.4 Alzheimer’s Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer’s Disease Diagnostic Players by Revenue
3.1.1 Global Top Alzheimer’s Disease Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Alzheimer’s Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alzheimer’s Disease Diagnostic Revenue
3.4 Global Alzheimer’s Disease Diagnostic Market Concentration Ratio
3.4.1 Global Alzheimer’s Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Diagnostic Revenue in 2024
3.5 Global Key Players of Alzheimer’s Disease Diagnostic Head office and Area Served
3.6 Global Key Players of Alzheimer’s Disease Diagnostic, Product and Application
3.7 Global Key Players of Alzheimer’s Disease Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer’s Disease Diagnostic Breakdown Data by Type
4.1 Global Alzheimer’s Disease Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Type (2026-2031)
5 Alzheimer’s Disease Diagnostic Breakdown Data by Application
5.1 Global Alzheimer’s Disease Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alzheimer’s Disease Diagnostic Market Size (2020-2031)
6.2 North America Alzheimer’s Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025)
6.4 North America Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer’s Disease Diagnostic Market Size (2020-2031)
7.2 Europe Alzheimer’s Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025)
7.4 Europe Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Alzheimer’s Disease Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer’s Disease Diagnostic Market Size (2020-2031)
9.2 Latin America Alzheimer’s Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Alzheimer’s Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Alzheimer’s Disease Diagnostic Introduction
11.1.4 Eli Lilly and Company Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.1.5 Eli Lilly and Company Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Alzheimer’s Disease Diagnostic Introduction
11.2.4 Novartis Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Alzheimer’s Disease Diagnostic Introduction
11.3.4 Merck Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.3.5 Merck Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Alzheimer’s Disease Diagnostic Introduction
11.5.4 Pfizer Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 TauRx
11.6.1 TauRx Company Details
11.6.2 TauRx Business Overview
11.6.3 TauRx Alzheimer’s Disease Diagnostic Introduction
11.6.4 TauRx Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.6.5 TauRx Recent Development
11.7 Alector
11.7.1 Alector Company Details
11.7.2 Alector Business Overview
11.7.3 Alector Alzheimer’s Disease Diagnostic Introduction
11.7.4 Alector Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.7.5 Alector Recent Development
11.8 Accera
11.8.1 Accera Company Details
11.8.2 Accera Business Overview
11.8.3 Accera Alzheimer’s Disease Diagnostic Introduction
11.8.4 Accera Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.8.5 Accera Recent Development
11.9 Treventis Corporation
11.9.1 Treventis Corporation Company Details
11.9.2 Treventis Corporation Business Overview
11.9.3 Treventis Corporation Alzheimer’s Disease Diagnostic Introduction
11.9.4 Treventis Corporation Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.9.5 Treventis Corporation Recent Development
11.10 Neuro-Bio
11.10.1 Neuro-Bio Company Details
11.10.2 Neuro-Bio Business Overview
11.10.3 Neuro-Bio Alzheimer’s Disease Diagnostic Introduction
11.10.4 Neuro-Bio Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.10.5 Neuro-Bio Recent Development
11.11 Cognition Therapeutics
11.11.1 Cognition Therapeutics Company Details
11.11.2 Cognition Therapeutics Business Overview
11.11.3 Cognition Therapeutics Alzheimer’s Disease Diagnostic Introduction
11.11.4 Cognition Therapeutics Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.11.5 Cognition Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Alzheimer’s Disease Diagnostic Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Nervous System Examination
1.2.3 Genetic Testing
1.2.4 Minor Mental State Examination (Mmse)
1.2.5 Brain Imaging
1.3 Market by Application
1.3.1 Global Alzheimer’s Disease Diagnostic Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Early-Onset Alzheimer's Disease
1.3.3 Familial Alzheimer's Disease
1.3.4 Late-Onset Alzheimer's Disease
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Alzheimer’s Disease Diagnostic Market Perspective (2020-2031)
2.2 Global Alzheimer’s Disease Diagnostic Growth Trends by Region
2.2.1 Global Alzheimer’s Disease Diagnostic Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Alzheimer’s Disease Diagnostic Historic Market Size by Region (2020-2025)
2.2.3 Alzheimer’s Disease Diagnostic Forecasted Market Size by Region (2026-2031)
2.3 Alzheimer’s Disease Diagnostic Market Dynamics
2.3.1 Alzheimer’s Disease Diagnostic Industry Trends
2.3.2 Alzheimer’s Disease Diagnostic Market Drivers
2.3.3 Alzheimer’s Disease Diagnostic Market Challenges
2.3.4 Alzheimer’s Disease Diagnostic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Alzheimer’s Disease Diagnostic Players by Revenue
3.1.1 Global Top Alzheimer’s Disease Diagnostic Players by Revenue (2020-2025)
3.1.2 Global Alzheimer’s Disease Diagnostic Revenue Market Share by Players (2020-2025)
3.2 Global Alzheimer’s Disease Diagnostic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Alzheimer’s Disease Diagnostic Revenue
3.4 Global Alzheimer’s Disease Diagnostic Market Concentration Ratio
3.4.1 Global Alzheimer’s Disease Diagnostic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Alzheimer’s Disease Diagnostic Revenue in 2024
3.5 Global Key Players of Alzheimer’s Disease Diagnostic Head office and Area Served
3.6 Global Key Players of Alzheimer’s Disease Diagnostic, Product and Application
3.7 Global Key Players of Alzheimer’s Disease Diagnostic, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Alzheimer’s Disease Diagnostic Breakdown Data by Type
4.1 Global Alzheimer’s Disease Diagnostic Historic Market Size by Type (2020-2025)
4.2 Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Type (2026-2031)
5 Alzheimer’s Disease Diagnostic Breakdown Data by Application
5.1 Global Alzheimer’s Disease Diagnostic Historic Market Size by Application (2020-2025)
5.2 Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Alzheimer’s Disease Diagnostic Market Size (2020-2031)
6.2 North America Alzheimer’s Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025)
6.4 North America Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Alzheimer’s Disease Diagnostic Market Size (2020-2031)
7.2 Europe Alzheimer’s Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025)
7.4 Europe Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size (2020-2031)
8.2 Asia-Pacific Alzheimer’s Disease Diagnostic Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2020-2025)
8.4 Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Alzheimer’s Disease Diagnostic Market Size (2020-2031)
9.2 Latin America Alzheimer’s Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025)
9.4 Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size (2020-2031)
10.2 Middle East & Africa Alzheimer’s Disease Diagnostic Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025)
10.4 Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eli Lilly and Company
11.1.1 Eli Lilly and Company Company Details
11.1.2 Eli Lilly and Company Business Overview
11.1.3 Eli Lilly and Company Alzheimer’s Disease Diagnostic Introduction
11.1.4 Eli Lilly and Company Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.1.5 Eli Lilly and Company Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Alzheimer’s Disease Diagnostic Introduction
11.2.4 Novartis Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Alzheimer’s Disease Diagnostic Introduction
11.3.4 Merck Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.3.5 Merck Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Alzheimer’s Disease Diagnostic Introduction
11.5.4 Pfizer Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.5.5 Pfizer Recent Development
11.6 TauRx
11.6.1 TauRx Company Details
11.6.2 TauRx Business Overview
11.6.3 TauRx Alzheimer’s Disease Diagnostic Introduction
11.6.4 TauRx Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.6.5 TauRx Recent Development
11.7 Alector
11.7.1 Alector Company Details
11.7.2 Alector Business Overview
11.7.3 Alector Alzheimer’s Disease Diagnostic Introduction
11.7.4 Alector Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.7.5 Alector Recent Development
11.8 Accera
11.8.1 Accera Company Details
11.8.2 Accera Business Overview
11.8.3 Accera Alzheimer’s Disease Diagnostic Introduction
11.8.4 Accera Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.8.5 Accera Recent Development
11.9 Treventis Corporation
11.9.1 Treventis Corporation Company Details
11.9.2 Treventis Corporation Business Overview
11.9.3 Treventis Corporation Alzheimer’s Disease Diagnostic Introduction
11.9.4 Treventis Corporation Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.9.5 Treventis Corporation Recent Development
11.10 Neuro-Bio
11.10.1 Neuro-Bio Company Details
11.10.2 Neuro-Bio Business Overview
11.10.3 Neuro-Bio Alzheimer’s Disease Diagnostic Introduction
11.10.4 Neuro-Bio Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.10.5 Neuro-Bio Recent Development
11.11 Cognition Therapeutics
11.11.1 Cognition Therapeutics Company Details
11.11.2 Cognition Therapeutics Business Overview
11.11.3 Cognition Therapeutics Alzheimer’s Disease Diagnostic Introduction
11.11.4 Cognition Therapeutics Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025)
11.11.5 Cognition Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Alzheimer’s Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nervous System Examination
Table 3. Key Players of Genetic Testing
Table 4. Key Players of Minor Mental State Examination (Mmse)
Table 5. Key Players of Brain Imaging
Table 6. Global Alzheimer’s Disease Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Alzheimer’s Disease Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Alzheimer’s Disease Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Alzheimer’s Disease Diagnostic Market Share by Region (2020-2025)
Table 10. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Alzheimer’s Disease Diagnostic Market Share by Region (2026-2031)
Table 12. Alzheimer’s Disease Diagnostic Market Trends
Table 13. Alzheimer’s Disease Diagnostic Market Drivers
Table 14. Alzheimer’s Disease Diagnostic Market Challenges
Table 15. Alzheimer’s Disease Diagnostic Market Restraints
Table 16. Global Alzheimer’s Disease Diagnostic Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Alzheimer’s Disease Diagnostic Market Share by Players (2020-2025)
Table 18. Global Top Alzheimer’s Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Diagnostic as of 2024)
Table 19. Ranking of Global Top Alzheimer’s Disease Diagnostic Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Alzheimer’s Disease Diagnostic Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Alzheimer’s Disease Diagnostic, Headquarters and Area Served
Table 22. Global Key Players of Alzheimer’s Disease Diagnostic, Product and Application
Table 23. Global Key Players of Alzheimer’s Disease Diagnostic, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alzheimer’s Disease Diagnostic Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2020-2025)
Table 27. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2026-2031)
Table 29. Global Alzheimer’s Disease Diagnostic Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2020-2025)
Table 31. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2026-2031)
Table 33. North America Alzheimer’s Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Alzheimer’s Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Alzheimer’s Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 48. Eli Lilly and Company Company Details
Table 49. Eli Lilly and Company Business Overview
Table 50. Eli Lilly and Company Alzheimer’s Disease Diagnostic Product
Table 51. Eli Lilly and Company Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 52. Eli Lilly and Company Recent Development
Table 53. Novartis Company Details
Table 54. Novartis Business Overview
Table 55. Novartis Alzheimer’s Disease Diagnostic Product
Table 56. Novartis Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. Merck Company Details
Table 59. Merck Business Overview
Table 60. Merck Alzheimer’s Disease Diagnostic Product
Table 61. Merck Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 62. Merck Recent Development
Table 63. F. Hoffmann-La Roche Company Details
Table 64. F. Hoffmann-La Roche Business Overview
Table 65. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Product
Table 66. F. Hoffmann-La Roche Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 67. F. Hoffmann-La Roche Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Alzheimer’s Disease Diagnostic Product
Table 71. Pfizer Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. TauRx Company Details
Table 74. TauRx Business Overview
Table 75. TauRx Alzheimer’s Disease Diagnostic Product
Table 76. TauRx Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 77. TauRx Recent Development
Table 78. Alector Company Details
Table 79. Alector Business Overview
Table 80. Alector Alzheimer’s Disease Diagnostic Product
Table 81. Alector Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 82. Alector Recent Development
Table 83. Accera Company Details
Table 84. Accera Business Overview
Table 85. Accera Alzheimer’s Disease Diagnostic Product
Table 86. Accera Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 87. Accera Recent Development
Table 88. Treventis Corporation Company Details
Table 89. Treventis Corporation Business Overview
Table 90. Treventis Corporation Alzheimer’s Disease Diagnostic Product
Table 91. Treventis Corporation Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 92. Treventis Corporation Recent Development
Table 93. Neuro-Bio Company Details
Table 94. Neuro-Bio Business Overview
Table 95. Neuro-Bio Alzheimer’s Disease Diagnostic Product
Table 96. Neuro-Bio Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 97. Neuro-Bio Recent Development
Table 98. Cognition Therapeutics Company Details
Table 99. Cognition Therapeutics Business Overview
Table 100. Cognition Therapeutics Alzheimer’s Disease Diagnostic Product
Table 101. Cognition Therapeutics Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 102. Cognition Therapeutics Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Alzheimer’s Disease Diagnostic Picture
Figure 2. Global Alzheimer’s Disease Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alzheimer’s Disease Diagnostic Market Share by Type: 2024 VS 2031
Figure 4. Nervous System Examination Features
Figure 5. Genetic Testing Features
Figure 6. Minor Mental State Examination (Mmse) Features
Figure 7. Brain Imaging Features
Figure 8. Global Alzheimer’s Disease Diagnostic Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Alzheimer’s Disease Diagnostic Market Share by Application: 2024 VS 2031
Figure 10. Early-Onset Alzheimer's Disease Case Studies
Figure 11. Familial Alzheimer's Disease Case Studies
Figure 12. Late-Onset Alzheimer's Disease Case Studies
Figure 13. Alzheimer’s Disease Diagnostic Report Years Considered
Figure 14. Global Alzheimer’s Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Alzheimer’s Disease Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Alzheimer’s Disease Diagnostic Market Share by Region: 2024 VS 2031
Figure 17. Global Alzheimer’s Disease Diagnostic Market Share by Players in 2024
Figure 18. Global Top Alzheimer’s Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Diagnostic as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Alzheimer’s Disease Diagnostic Revenue in 2024
Figure 20. North America Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Alzheimer’s Disease Diagnostic Market Share by Country (2020-2031)
Figure 22. United States Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Alzheimer’s Disease Diagnostic Market Share by Country (2020-2031)
Figure 26. Germany Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Alzheimer’s Disease Diagnostic Market Share by Region (2020-2031)
Figure 34. China Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Alzheimer’s Disease Diagnostic Market Share by Country (2020-2031)
Figure 42. Mexico Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Alzheimer’s Disease Diagnostic Market Share by Country (2020-2031)
Figure 46. Turkey Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Eli Lilly and Company Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 50. Novartis Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 51. Merck Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 52. F. Hoffmann-La Roche Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 53. Pfizer Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 54. TauRx Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 55. Alector Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 56. Accera Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 57. Treventis Corporation Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 58. Neuro-Bio Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 59. Cognition Therapeutics Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Table 1. Global Alzheimer’s Disease Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Nervous System Examination
Table 3. Key Players of Genetic Testing
Table 4. Key Players of Minor Mental State Examination (Mmse)
Table 5. Key Players of Brain Imaging
Table 6. Global Alzheimer’s Disease Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Alzheimer’s Disease Diagnostic Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Alzheimer’s Disease Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Alzheimer’s Disease Diagnostic Market Share by Region (2020-2025)
Table 10. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Alzheimer’s Disease Diagnostic Market Share by Region (2026-2031)
Table 12. Alzheimer’s Disease Diagnostic Market Trends
Table 13. Alzheimer’s Disease Diagnostic Market Drivers
Table 14. Alzheimer’s Disease Diagnostic Market Challenges
Table 15. Alzheimer’s Disease Diagnostic Market Restraints
Table 16. Global Alzheimer’s Disease Diagnostic Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Alzheimer’s Disease Diagnostic Market Share by Players (2020-2025)
Table 18. Global Top Alzheimer’s Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Diagnostic as of 2024)
Table 19. Ranking of Global Top Alzheimer’s Disease Diagnostic Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Alzheimer’s Disease Diagnostic Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Alzheimer’s Disease Diagnostic, Headquarters and Area Served
Table 22. Global Key Players of Alzheimer’s Disease Diagnostic, Product and Application
Table 23. Global Key Players of Alzheimer’s Disease Diagnostic, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Alzheimer’s Disease Diagnostic Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2020-2025)
Table 27. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Type (2026-2031)
Table 29. Global Alzheimer’s Disease Diagnostic Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2020-2025)
Table 31. Global Alzheimer’s Disease Diagnostic Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Alzheimer’s Disease Diagnostic Revenue Market Share by Application (2026-2031)
Table 33. North America Alzheimer’s Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Alzheimer’s Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Alzheimer’s Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size by Country (2026-2031) & (US$ Million)
Table 48. Eli Lilly and Company Company Details
Table 49. Eli Lilly and Company Business Overview
Table 50. Eli Lilly and Company Alzheimer’s Disease Diagnostic Product
Table 51. Eli Lilly and Company Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 52. Eli Lilly and Company Recent Development
Table 53. Novartis Company Details
Table 54. Novartis Business Overview
Table 55. Novartis Alzheimer’s Disease Diagnostic Product
Table 56. Novartis Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 57. Novartis Recent Development
Table 58. Merck Company Details
Table 59. Merck Business Overview
Table 60. Merck Alzheimer’s Disease Diagnostic Product
Table 61. Merck Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 62. Merck Recent Development
Table 63. F. Hoffmann-La Roche Company Details
Table 64. F. Hoffmann-La Roche Business Overview
Table 65. F. Hoffmann-La Roche Alzheimer’s Disease Diagnostic Product
Table 66. F. Hoffmann-La Roche Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 67. F. Hoffmann-La Roche Recent Development
Table 68. Pfizer Company Details
Table 69. Pfizer Business Overview
Table 70. Pfizer Alzheimer’s Disease Diagnostic Product
Table 71. Pfizer Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 72. Pfizer Recent Development
Table 73. TauRx Company Details
Table 74. TauRx Business Overview
Table 75. TauRx Alzheimer’s Disease Diagnostic Product
Table 76. TauRx Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 77. TauRx Recent Development
Table 78. Alector Company Details
Table 79. Alector Business Overview
Table 80. Alector Alzheimer’s Disease Diagnostic Product
Table 81. Alector Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 82. Alector Recent Development
Table 83. Accera Company Details
Table 84. Accera Business Overview
Table 85. Accera Alzheimer’s Disease Diagnostic Product
Table 86. Accera Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 87. Accera Recent Development
Table 88. Treventis Corporation Company Details
Table 89. Treventis Corporation Business Overview
Table 90. Treventis Corporation Alzheimer’s Disease Diagnostic Product
Table 91. Treventis Corporation Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 92. Treventis Corporation Recent Development
Table 93. Neuro-Bio Company Details
Table 94. Neuro-Bio Business Overview
Table 95. Neuro-Bio Alzheimer’s Disease Diagnostic Product
Table 96. Neuro-Bio Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 97. Neuro-Bio Recent Development
Table 98. Cognition Therapeutics Company Details
Table 99. Cognition Therapeutics Business Overview
Table 100. Cognition Therapeutics Alzheimer’s Disease Diagnostic Product
Table 101. Cognition Therapeutics Revenue in Alzheimer’s Disease Diagnostic Business (2020-2025) & (US$ Million)
Table 102. Cognition Therapeutics Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report
List of Figures
Figure 1. Alzheimer’s Disease Diagnostic Picture
Figure 2. Global Alzheimer’s Disease Diagnostic Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Alzheimer’s Disease Diagnostic Market Share by Type: 2024 VS 2031
Figure 4. Nervous System Examination Features
Figure 5. Genetic Testing Features
Figure 6. Minor Mental State Examination (Mmse) Features
Figure 7. Brain Imaging Features
Figure 8. Global Alzheimer’s Disease Diagnostic Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Alzheimer’s Disease Diagnostic Market Share by Application: 2024 VS 2031
Figure 10. Early-Onset Alzheimer's Disease Case Studies
Figure 11. Familial Alzheimer's Disease Case Studies
Figure 12. Late-Onset Alzheimer's Disease Case Studies
Figure 13. Alzheimer’s Disease Diagnostic Report Years Considered
Figure 14. Global Alzheimer’s Disease Diagnostic Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Alzheimer’s Disease Diagnostic Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Alzheimer’s Disease Diagnostic Market Share by Region: 2024 VS 2031
Figure 17. Global Alzheimer’s Disease Diagnostic Market Share by Players in 2024
Figure 18. Global Top Alzheimer’s Disease Diagnostic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Alzheimer’s Disease Diagnostic as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Alzheimer’s Disease Diagnostic Revenue in 2024
Figure 20. North America Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Alzheimer’s Disease Diagnostic Market Share by Country (2020-2031)
Figure 22. United States Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Alzheimer’s Disease Diagnostic Market Share by Country (2020-2031)
Figure 26. Germany Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Alzheimer’s Disease Diagnostic Market Share by Region (2020-2031)
Figure 34. China Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Alzheimer’s Disease Diagnostic Market Share by Country (2020-2031)
Figure 42. Mexico Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Alzheimer’s Disease Diagnostic Market Share by Country (2020-2031)
Figure 46. Turkey Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Alzheimer’s Disease Diagnostic Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Eli Lilly and Company Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 50. Novartis Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 51. Merck Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 52. F. Hoffmann-La Roche Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 53. Pfizer Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 54. TauRx Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 55. Alector Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 56. Accera Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 57. Treventis Corporation Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 58. Neuro-Bio Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 59. Cognition Therapeutics Revenue Growth Rate in Alzheimer’s Disease Diagnostic Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Potassium Bromide Windows Market Research Report 2025
Dec 14, 25
Global Bio-based 1,10-Decanediol Diacrylate Market Research Report 2025
Dec 14, 25
Global Bio-based 1,5-Pentanediol Diacrylate(PDDA) Market Research Report 2025
Dec 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232